David Young
CIK 1378166 · Pres. Research & Development · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$38.1K
Companies
3
Total Filings
63
Lifetime Open-Market Net
-$14.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCSA | Pres. Research & Development | 17,563 | $2.17 | $38.1K | $373.0K | 37 | 2026-06-01 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Chief Scientific Officer | 122,366 | — | — | -$14.87M | 21 | 2014-03-18 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Director | — | — | — | $0 | 4 | 2008-01-03 |
Recent Filings · Page 7 of 7
63 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-07-18 | QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-15 | QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-01-04 | QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 61–63 of 63
Prev
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.